Nuclear import as a barrier to infection of human umbilical vein endothelial cells by human cytomegalovirus strain AD169

Virus Research

Volumn 56, Issue 2, 1998, Pages 149-156

  Slobbe Van Drunen, M E P ^a   Hendrickx, A T M ^a   Vossen, R C R M ^a   Speel, E J M ^a   Van Dam Mieras, M C E ^a,b   Bruggeman, C A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b OPEN UNIVERSITY OF THE NETHERLANDS   (Netherlands)

Author keywords

Human cytomegalovirus; Human embryonal fibroblasts; Human umbilical vein endothelial cells; In situ hybridisation

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN;

ANTIGENS, VIRAL; CELL NUCLEUS; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA, VIRAL; EMBRYO; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; TIME FACTORS; UMBILICAL VEINS; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 0032144191     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(98)00064-1     Document Type: Article

References (26)

1. Baskar J.F., Smith P.P., Nilaver G., Jupp R.A., Hoffmann S., Peffer N.J., Ghazal P., Nelson J.A. The enhancer domein of the human cytomegalovirus major immediate-early promotor determines cell type-specific expression in transgenic mice. J. Virol. 70:1996;3207-3214.
2. Baum E.Z., Siegel M.M., Bebernitz G.A. et al. Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation. Biochemistry. 35:1996;5838-5846.
3. Davis D.A., Dorsey K., Wingfield P.T., Stahl S.J., Kaufman J., Fales H.M., Levine R.L. Regulation of HIV-1 protease activity through cysteine modification. Biochemistry. 35:1996;2482-2488.
4. Detrick B., Rhame J., Wang Y., Nagineni C.N., Hooks J.J. Cytomegalovirus replication in human retinal pigment epithelial cells. Altered expression of viral early proteins. Invest. Ophthalmol. Vis. Sci. 37(5):1996;814-825.
5. Fish K.N., Depto A.S., Moses A.V., Britt W., Nelson J.A. Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J. Virol. 69(6):1995;3737-3743.
6. Fleckenstein B., Müller I., Collins J. Cloning the complete human cytomegalovirus genome in cosmids. Gene. 18:1982;39-46.
7. Gleaves C.A., Smith T.F., Shuster E.A., Pearson G.R. Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens. J. Clin. Microbiol. 21:1985;217-221.
8. Graham R.C., Karnovsky M.J. The early stages of absorption of injected horseradish peroxidase in the proximal tissue of the mouse kidney with structural cytochemistry by a new technique. J. Histochem. Cytochem. 14:1966;291-302.
9. Greber U.F., Webster P., Weber J., Helenius A. The role of the adenovirus protease on virus entry into cells. EMBO J. 15(8):1996;1766-1777.
10. Ho D.D., Rota T.R., Andrews C.A., Hirsch M.S. Replication of human cytomegalovirus in endothelial cells. J. Infect. Dis. 150:1984;956-957.
11. Lathey J.L., Wiley C.A., Verity M.A., Nelson J.A. Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus. Virology. 176(1):1990;266-273.
12. Maidji E., Tugizov S., Jones T., Zheng Z., Pereira L. Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J. Virol. 70:1996;8402-8410.
13. Merigan T.C., Resta S. Cytomegalovirus: where have we been and where are we going? Rev. Infect. Dis. 12(7):1990;693-700.
14. Meyerson D., Hackman R.C., Nelson J.A., McDoughall J.K. Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15:1984;430-438.
15. Nagy K., Young M., Baboonian C., Merson J., Whittle P., Oroszlan S. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase. J. Virol. 68(2):1994;757-765.
16. Nowlin D.M., Cooper N.R., Compton T. Expression of a human cytomegalovirus receptor correlates with infectibility of the cells. J. Virol. 65(6):1991;3114-3121.
17. Persoons M.C.J., Stals F.S., van Dam-Mieras M.C.E., Bruggeman C.A. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J. Pathol. 183:1997.
18. Roberts W.H., Sneddon J.M., Waldman J., Stephens R.E. Cytomegalovirus infection of gastrointestinal endothelium demonstrated by simultaneous nucleic acid hybridisation and immunohistochemistry. Arch. Pathol. Lab. Med. 113:1989;461-464.
19. Sinzger C., Grefte A., Plachter B., Gouw A.S.H., Hauw The T., Jahn G. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76:1995;741-750.
20. Slobbe van Drunen M.E.P., Vossen R.C.R.M., Couwenberg F.M.D., Hulsbosch M.M., Heemskerk J.W.M., van Dam-Mieras M.C.E., Bruggeman C.A. Activation of protein kinase C enhances the infection of endothelial cells by human cytomegalovirus. Virus Res. 48:1997;207-213.
21. Span A.H., Frederik P.M., Grauls G., van Boven G.P., Bruggeman C.A. CMV induced vascular injury: an electron-microscopic study in rat. In Vivo. 7:1993;567-573.
22. Span A.H., Mullers W., Miltenburg A.M., Bruggeman C.A. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. Immunology. 72(3):1991;355-360.
23. Speel E.J.M., Jansen M.P.H.M., Ramaekers F.C.S., Hopman A.H.N. A novel triple-color detection procedure for brightfield microscopy, combinding in situ hybridisation with immunocytochemestry. J. Histochem. Cytochem. 42:1994;1299-1307.
24. Vossen R.C.R.M., Derhaag J.G., Slobbe-van Drunen M.E.P., Duijvenstijn A.M., van Dam-Mieras M.C.E., Bruggeman C.A. A dual role for endothelial cells in cytomegalovirus infection? A study of cytomegalovirus infection in a series of rat endothelial cell lines. Virus Res. 46:1996;65-74.
25. Vossen R.C.R.M., Persoons M.C.J., Slobbe-van Drunen M.E.p., Bruggeman C.A., van Dam-Mieras M.C.E. Intracellular thiol redox status affects cytomegalovirus infection of vascular cells. Virus Res. 48:1997;173-183.
26. Waldman W.J., Sneddon J.M., Stephens R.E., Roberts W.H. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J. Med. Virol. 28(4):1989;223-230.